remote health monitoring

presented by
Devices & Diagnostics

Analyst sees Medtronic’s new business strategy as indicator of ‘challenging outlook for medtech’

Not everyone’s buying Medtronic‘s (MDT) new do. On the heels of Medtronic’s Q1 results report, Deutsche Bank analyst Greg Poole had this to say: . . . of greater interest to us was management’s commentary on the quarterly call regarding its strategy of transforming from a device provider to a global medical technology solutions partner. While […]